Clinical Trial Update: Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses [Phase 4]

View source ↗

Summary

A Phase 4 study assessed ACTHAR's effects on MRI-based disease activity markers and immune signatures during Multiple Sclerosis relapses. The trial was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: University of Chicago | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED | Results posted: 2024-05-16